Molecular approach to identify antidiabetic potential of Azadirachta indica

Journal of Ayurveda and Integrative Medicine

Volumn 6, Issue 3, 2015, Pages 165-174

  Satyanarayana, K ^a   Sravanthi, K ^b   Shaker, I ^a   Ponnulakshmi, R ^c  

^a BHARATH UNIVERSITY   (India)

^b Department of Pharmacology   (India)

^c ETHIRAJ COLLEGE FOR WOMEN   (India)

Author keywords

Azadirachta indica; high fat diet; insulin resistance; type 2 diabetes

Indexed keywords

AZADIRACHTA INDICA EXTRACT; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; METFORMIN; PROTEIN KINASE B; SERINE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 84944043588     PISSN: 09759476     EISSN: 09762809     Source Type: Journal    
DOI: 10.4103/0975-9476.157950     Document Type: Article

References (49)

1. International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011. Available from: Online version of IDF Diabetes Atlas: www.idf.org/diabetesatlas. ISBN: 2-930229-85-3.
2. Valiathan MS. Healing plants. Curr Sci 1998;75:1122-7.
3. Singh SK, Rai PK, Jaiswal D, Watal G. Evidence-based Critical evaluation of glycemic potential of Cynodon dactylon. Evid Based Complement Alternat Med 2008;5:415-20.
4. Home P, Mant J, Diaz J, Turner C, Guideline Development Group. Management of type 2 diabetes: Summary of updated NICE guidance. BMJ 2008;336:1306-8.
5. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005;365:1333-46.
6. Venkateswaran S, Pari L. Effect of Coccinia indica leaves on antioxidant status in streptozotocin-induced diabetic rats. J Ethnopharmacol 2003;84:163-8.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2007;30:4-41.
8. Sharma B, Salunke R, Balomajumder C, Daniel S, Roy P. Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice. J Ethnopharmacol 2010;127:457-62.
9. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay V. Biological and medicinal properties of Neem (Azadirachta indica). Curr Sci 2002;82:1136-45.
10. Chopra RN, Chopra IC. A review of work on Indian Medicinal plants including indigenous drugs and poisonous plants. Special Research Series No. 30. Location: UniM BioMed ST, ICMR; 1955. p. 27.
11. Satyanarayana MK, Narayana RD, Krishna, RD, Gopalakrishna ML. A preliminary study on hypoglycaemic and antihyperglycaemic effects of Azadirachta indica. Indian J Pharmacol 1978;10:247-50.
12. Rochanakij S, Thebtaranonth Y, Yenjai C, Yuthavong Y. Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture. Southeast Asian J Trop Med Public Health 1985;16:66-72.
13. Shukia R, Sharma SB, Puri D, Prabhu KM, Murthy PS. Medicinal plants for treatment of diabetes mellitus. Indian J Clin Biochem 2000;15:169-77.
14. El-Hawary ZM, Kholeif TS. Biochemical studies on hypoglycemic agents (1) Effect of Azadirachta indica leaf extract. Arch Phytother Res 1990;13:108-12.
15. Mahdi AA, Chandra A, Singh RK, Shukla S, Mishra LC, Ahmad S. Effect of herbal hypoglycemic agents on oxidative stress and antioxidant status in diabetic rats. Indian J Clin Biochem 2003;18:8-15.
16. Shrivastava A, Chaturvedi U, Sonkar R, Khanna AK, Saxena JK, Bhatia G. Antioxidant effect of Azadirachta indica on high fat diet induced diabetic Charles Foster rats. Appl Biochem Biotechnol 2012;167:229-36.
17. Akinola O, Ezekiel A, Dini CM. Diabetes-induced prefrontal nissl substance deficit and the effects of Neem-Bitter leaf extract treatment. J Morphol 2010;28:291-302.
18. Akpan HD, Ekaidem IS, Usoh IF, Ebong PE, Isong NB. Effect of aqueous extract of Azadirachta indica (Neem) leaves on some indices of pancreatic function in alloxan-induced diabetic wistar rats. Pharmacologia 2012;3:420-5.
19. Balaji V, Selvaraj J, Sathish S, Mayilvanan C, Balasubramanian K. Molecular mechanism underlying the antidiabetic effects of a siddha polyherbal preparation in the liver of type-2 diabetic adult male rats. J Evid Based Complementary Altern Med 2012;00:1-14.
20. Kraft LA, Johnson AD. Epididymal carbohydrate metabolism. II. Substrates and pathway utilization of caput and cauda epididymal tissue from the rabbit, rat and mouse. Comp Biochem Physiol B 1972;42:451-61.
21. Hassid WZ, Abraham S. Determination of glycogen with anthrone reagent. Methods Enzymol 1975;3:34-7.
22. Dombrowski L, Roy D, Marcotte B, Marette A. A new procedure for the isolation of plasma membranes, T tubules, and internal membranes from skeletal muscle. Am J Physiol 1996;270:E667-76.
23. Nevado C, Valverde AM, Benito M. Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Endocrinology 2006;147:3709-18.
24. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985;76:149-55.
25. Qi Z, Xue J, Zhang Y, Wang H, Xie M. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats. Planta Med 2011;77:231-5.
26. Kandasamy AD, Sung MM, Boisvenue JJ, Barr AJ, Dyck JR. Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. Nutr Diabetes 2012;2:e45.
27. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH (2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307). J Biol Chem 2000;275:9047-54.
28. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 2002;277:48115-21.
29. De Fea K, Roth RA. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem 1997;272:31400-6.
30. Liu YF, Paz K, Herschkovitz A, Alt A, Tennenbaum T, Sampson SR, et al. Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 2001;276:14459-65.
31. Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, et al. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser (1101). J Biol Chem 2004;279:45304-7.
32. Zhang XF, Tan BK. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore Med J 2000;41:9-13.
33. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 2003;178:373-83.
34. Taniguchi CM, Ueki K, Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 2005;115:718-27.
35. Petruzzelli LM, Ganguly S, Smith CJ, Cobb MH, Rubin CS, Rosen OM. Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta. Proc Natl Acad Sci U S A 1982;79:6792-6.
36. Bhattacharya S, Dey D, Roy SS. Molecular mechanism of insulin resistance. J Biosci 2007;32:405-13.
37. Chattopadhyay RR, Bandyopadhyay M. Effect of Azadirachta indica leaf extract on serum lipid profile changes in normal and streptozotocin induced diabetic rats. Afr J Biomed Res 2005;8:101-4.
38. Chattopadhyay RR. Possible mechanism of antihyperglycemic effect of Azadirachta indica leaf extract: part V. J Ethnopharmacol 1999;67:373-6.
39. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002;51:2005-11.
40. Sumiyoshi M, Sakanaka M, Kimura Y. Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 2006;136:582-7.
41. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: Unravelling the mechanism. Lancet 2010;375:2267-77.
42. Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes 2010;1:68-75.
43. Sano H, Kane S, Sano E, Mîinea CP, Asara JM, Lane WS, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 2003;278:14599-602.
44. Zaid H, Antonescu CN, Randhawa VK, Klip A. Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J 2008;413:201-15.
45. Karnieli E, Armoni M. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: From physiology to pathology. Am J Physiol Endocrinol Metab 2008;295:E38-45.
46. Geetha R, Yogalakshmi B, Sreeja S, Bhavani K, Anuradha CV. Troxerutin suppresses lipid abnormalities in the heart of high-fat-high-fructose diet-fed mice. Mol Cell Biochem 2014;387:123-34.
47. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: Evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007;56:2085-92.
48. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995-28;378:785-9.
49. Anne AW, Akilavalli N, Mangalapriya V, Balasubramanian. Evaluation of antidiabetic property of Andrographis paniculata powder in high fat and sucrose-induced type-2 diabetic adult male rat. Asian Pac J Trop Dis 2014;4:930-7.